Moclobemide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Moclobemide, covering 2015-07-29 to 2015-07-29. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers [Phase 2]